Friday, 19 Jul 2019

You are here

Timing of Shoulder Injections Impacts Surgical Infection Risk

A study of patients undergoing arthroscopic rotator cuff repair shows that corticosteroid injections in the month prior to surgery are associated with a significantly increased risk of surgical site infection.

A large claims database review examined patients undergoing arthroscopic rotator cuff repair and compared those undergoing arthroscopic rotator cuff repair within 1 year of injection (n=12,060), and those undergoing arthroscopic rotator cuff repair without prior injection (n = 48,763).  The primary outcome was surgical site infection within 6 months of the procedure. 

While there was no overall difference in the incidence of surgical site infection in patients receiving a shoulder injection (0.7%) and those without injection (0.8%), the investigators did find a significantly higher rate of infection in patients receiving an injection within 1 month prior (1.3% vs 0.8%; R, 1.7 [95% CI, 1.0 to 2.9]; p = 0.04).

Risk factors for infections included being male (OR, 1.7), obesity (OR 1.4), diabetes (OR 1.3), smoking (OR 1.7) and and preoperative corticosteroid injections within 1 month of the surgical procedure (OR, 2.1). 

Corticosteroid injections should be avoided if surgical arthroscopic rotator cuff repair is soon contemplated. 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Rituximab Superior to Cyclosporine for Membranous Nephropathy

The NEJM has reported that rituximab (RTX) and cyclosporine (CYA) was noninferior to cyclosporine in inducing complete or partial remission of proteinuria at 12 months and was superior in maintaining proteinuria remission up to 24 months. 

Management of Hemophagocytic Lymphohistiocytosis (HLH) in Adults

Hemophagocytic lymphohistiocytosis (HLH) is a severe hyperinflammatory syndrome induced by activated macrophages and cytotoxic T cells.  HLH manifests recurrent fever, cytopenia, liver dysfunction, and a sepsis-like syndrome that may complicated by multiple organ failure.

More Trouble for Mallinckrodt’s Acthar Gel

Reuters has reported that Mallinckrodt Plc has tentatively agreed to pay $15.4 million to resolve a US Justice Department investigation into company promotional practices for Acthar gel.

FDA Public Review of CBD Oil

The US Food and Drug Administration convened a public hearing and specialty panel on May 31st to review the potential use, safety and effectiveness of cannabidiol (CBD) products that do not contain THC.

In his opening remarks, the FDA acting Commissioner Dr. Ned Sharpless said, "critical questions remain about the safety" of CBD products, especially since the growth of the CBD market has exploded in the past year.

Steroids, Not Biologics, Drive Arthroplasty Infections in RA

Medicare and Truven MarketScan administrative data study (2006 through 2015) of rheumatoid arthritis (RA) undergoing arthroplasty found that while that the risks of perioperative infection was similar across biologics, the infection risk with glucocorticoid use, especially at > 10 mg/d, was significantly greater.